Drug intelligence / Profile preview

Tru Niagen Immune

Development stage
Unknown
Lead developer
Niagen Bioscience
Modality
Small Molecules
Administration
Oral
01

Overview

Tru Niagen Immune is a multi-ingredient dietary supplement developed and marketed by ChromaDex Corp. under the Tru Niagen brand. It is specifically formulated to support year-round immune health and cellular energy. The product's primary active ingredient is **Niagen** (nicotinamide riboside chloride), a patented small molecule precursor to **nicotinamide adenine dinucleotide (NAD+)**. NAD+ is a vital coenzyme found in all living cells that plays a crucial role in energy metabolism and maintaining cellular health, but its levels can be depleted by physiological stressors, including immune challenges. The current formulation of Tru Niagen Immune includes 100mg of Niagen, plant-based Vitamin D3 (VegD3), fermentation-derived Vitamin C, zinc in two bioavailable forms, selenium, and copper. An earlier version of the product contained 150mg of Niagen and included Theracurmin (a highly absorbable curcumin). It is designed as a daily companion supplement to be taken alongside standard Tru Niagen NAD+ boosters for comprehensive cellular and immune support.

Brand names
Tru Niagen Immune
02

Targets

NAD (Nicotinamide adenine dinucleotide)

Beyond the preview

Go deeper on Tru Niagen Immune.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tru Niagen Immune.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call